Lincomycin hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for lincomycin hydrochloride and what is the scope of patent protection?
Lincomycin hydrochloride
is the generic ingredient in two branded drugs marketed by Pharmacia And Upjohn, Pfizer, Arthur Grp, Gland Pharma Ltd, Micro Labs, Slate Run Pharma, Slayback, and Xgen Pharms, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for lincomycin hydrochloride. Ten suppliers are listed for this compound.
Summary for lincomycin hydrochloride
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 8 |
| NDAs: | 8 |
| Drug Master File Entries: | 10 |
| Finished Product Suppliers / Packagers: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 133 |
| Clinical Trials: | 3 |
| Patent Applications: | 1,742 |
| What excipients (inactive ingredients) are in lincomycin hydrochloride? | lincomycin hydrochloride excipients list |
| DailyMed Link: | lincomycin hydrochloride at DailyMed |
Recent Clinical Trials for lincomycin hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Menzies School of Health Research | Phase 4 |
| The Peter Doherty Institute for Infection and Immunity | Phase 4 |
| Sunnybrook Health Sciences Centre | Phase 4 |
Medical Subject Heading (MeSH) Categories for lincomycin hydrochloride
Anatomical Therapeutic Chemical (ATC) Classes for lincomycin hydrochloride
US Patents and Regulatory Information for lincomycin hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gland Pharma Ltd | LINCOMYCIN HYDROCHLORIDE | lincomycin hydrochloride | INJECTABLE;INJECTION | 215657-001 | Sep 26, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pfizer | LINCOCIN | lincomycin hydrochloride | INJECTABLE;INJECTION | 050317-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Slayback | LINCOMYCIN HYDROCHLORIDE | lincomycin hydrochloride | INJECTABLE;INJECTION | 063180-001 | Apr 16, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Micro Labs | LINCOMYCIN HYDROCHLORIDE | lincomycin hydrochloride | INJECTABLE;INJECTION | 215082-001 | Nov 8, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pharmacia And Upjohn | LINCOCIN | lincomycin hydrochloride | CAPSULE;ORAL | 050316-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
